Gastrin, motilin and pancreatic polypeptide levels after two different parenteral regimens in infants

What Was Tested

Researchers studied Pancreatic Polypeptide in the context of pancreatitis (after the acute phase) in this controlled clinical trial publication.

Wide interindividual fluctuations were noted, especially for motilin and PP, but, except for PP, intraindividual fluctuations were low.

Indeed, a good correlation was found, not only between the 2 pre-infusion levels, but also between pre- and postinfusion levels in both experiments.

Who Took Part

The abstract describes 15 children taking part.

PubMed indexes the participants as infants and young children.

In 15 children, aged 1-25 months, plasma peptide levels were measured by radioimmunoassay in the fasting state and after a 2-h infusion of either a mixture of amino acids, glucose and lipids (A) or a mixture of amino acids and glucose (B) only.

How the Study Was Run

The design is described as randomized.

Because people in this Pancreatic Polypeptide study were split into groups at random, differences between the groups are less likely to reflect who happened to join each one.

What Was Measured

Indeed, a good correlation was found, not only between the 2 pre-infusion levels, but also between pre- and postinfusion levels in both experiments.

The subject headings attached to it are Amino Acids, Fat Emulsions, Intravenous, Gastrins, Glucose, Motilin, Pancreatic Polypeptide and Parenteral Nutrition.

What This Means in Plain Language

The paper is a randomized study of Pancreatic Polypeptide in 15 children in people with pancreatitis (after the acute phase).

With fewer than 40 people, it is a small study, so it is better read as an early signal for further research than as a settled answer.

The publication is from 1990 (Reproduction, nutrition, development), a journal based in France.

More context: the Pancreatic Polypeptide compound page, Pancreatitis (after the acute phase) research.